AI assistant
Merus N.V. — Director's Dealing 2020
Feb 27, 2020
30810_dirs_2020-02-26_6279423d-5555-4241-b689-7d52766b3ddd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merus N.V. (MRUS)
CIK: 0001651311
Period of Report: 2020-02-24
Reporting Person: Throsby Mark (EVP & Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-24 | Common Shares | M | 87621 | — | Acquired | 100903 | Direct |
| 2020-02-24 | Common Shares | S | 57088 | $17.74 | Disposed | 43815 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-24 | Share Option (right to buy) | $ | M | 3333 | Disposed | 2020-09-04 | Common Shares (3333) | Direct |
| 2020-02-24 | Share Option (right to buy) | $ | M | 5000 | Disposed | 2022-06-17 | Common Shares (5000) | Direct |
| 2020-02-24 | Share Option (right to buy) | $ | M | 31472 | Disposed | 2023-03-16 | Common Shares (31472) | Direct |
| 2020-02-24 | Share Option (right to buy) | $ | M | 47816 | Disposed | 2023-10-30 | Common Shares (47816) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: Exercise prices are denominated in Euros and ranged from 1.93 to 7.20, with a weighted average of 4.81.
F3: Amount represents the weighted average price of shares sold, which ranged from $17.07 to $18.56. Details of individual transactions are available upon request.
F4: Exercise price is denominated in Euros at 1.93.
F5: These options are fully vested.
F6: Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on September 4, 2012.
F7: Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on June 17, 2014.
F8: Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on March 16, 2015.
F9: Exercise price is denominated in Euros at 7.20.
F10: Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on October 30, 2015.